TABLE 1.
Summary of clinical data for members in hearing loss families
| Patient | Gender | Age at test (y) | Age at onset | Use of aminoglycoside | PTA (dB) right ear | PTA (dB) left ear | Level of hearing impairment |
|---|---|---|---|---|---|---|---|
| F052* Ⅱ‐2 | Male | 63 | 20 | No | 96.5 | 95 | Profound |
| F052* Ⅱ‐3 | Female | 60 | — | No | 12.5 | 12.5 | Normal |
| F052* Ⅱ‐4 | Female | 60 | 30 | No | 90 | 83.75 | Profound |
| F052* Ⅲ‐1 | Female | 34 | 15 | No | 78.75 | 76.25 | Severe |
| F052* Ⅲ‐2 | Male | 29 | 10 | No | 95 | 82.5 | Profound |
| F493* Ⅱ‐1 | Male | 56 | 17 | No | 78.75 | 72.5 | Severe |
| F493* Ⅱ‐2 | Male | 53 | 20 | No | 72.5 | 72.5 | Severe |
| F493* Ⅱ‐4 | Male | 52 | 12 | No | 72.5 | 63.75 | Severe |
| F493* Ⅲ‐1 | Female | 32 | 17 | No | 61.25 | 57.5 | Moderate |
| F493* Ⅲ‐2 | Male | 30 | — | No | 12.5 | 12.5 | Normal |